HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, has developed partnerships with leading innovative next-generation sequencing (NGS) instrument providers and announces compatibility of the SEQuoia RNA Sequencing Library Preparation portfolio on new state-of-the-art sequencers, including the Singular Genomics G4™ System.  Recent compatibility […]

Effortless cell culture checks and reproducibility in every lab Wetzlar, Germany –­ Leica Microsystems, a leader in microscopy and scientific instrumentation, has launched Mateo TL, a digital transmitted light inverted microscope for cell culture routine. Mateo TL enables all lab members to check and document cell growth conveniently and comfortably. By measuring confluency consistently, they […]

First isoPick™ showcases at upcoming ELRIG CRISPR IN DRUG DISCOVERY 2023 event in Oxford (UK) and SLAS 2023 meeting in San Diego (USA) OXFORD, UK — iotaSciences, a spin-out from Oxford University in the field of single-cell handling solutions announced today product development completion for its newly built single cell picker instrumentation isoPick™. isoPick™ represents a powerful addition to iotaSciences´ existing […]

Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics     Caption: RoboCell cell line automation platform.    BURLINGTON, Ontario –  Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring […]

Customers can now access company’s groundbreaking technology without an instrument purchase to quickly generate the industry’s highest-quality 3D spatial transcriptomics data MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced the expansion of its end-to-end Meridian service offering for spatial transcriptomics data. Scientists who do not have access to […]

Developing synthetic cells for a range of applications in diagnostics and therapeutics EMERYVILLE, Calif. — Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform for customizing cell and cell line mimics, today announced the closing of $11 million in a Series A3 financing. The investment was co-led by ARCH Venture Partners and Northpond Ventures, […]

NEWARK, Calif. – Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced a collaboration to develop and enable use of New England Biolabs’ (NEB®) NEBNext® reagents and library preparation kits on Ultima sequencing platforms. As part of the collaboration, the parties will develop optimized next generation sequencing (NGS) workflows to […]

Singapore – SciMed (Asia) Pte Ltd (headquarters: Pandan Loop, Singapore, hereafter SciMed), a leading distributor of life sciences and healthcare products in Southeast Asia, announced that it has renewed its strategic relationship with Corning Incorporated (headquarters: New York, USA, hereafter Corning), one of the world’s leading innovators in materials science. With this relationship, SciMed’s product […]

New BD Rhapsody™ HT Xpress System and Other Innovations to be Unveiled at AGBT, Enhancing an End-To-End Single-Cell Multiomics Offering FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing […]

CAMBRIDGE, Mass. — Via Scientific, Inc., a new Cambridge based technology and AI company, is proud to announce the launch of Foundry, a multi-omics accelerator platform focused on significantly shortening the path to scientific breakthroughs. The Foundry platform was originally developed at UMass Chan Medical School; Via Scientific has exclusive commercial rights to the platform.   Founders of the […]